Ethyl 5-ethoxy-2-methyloxazole-4-carboxylate, 98%, 250mg

1,2:3,4-Di-O-isopropylidene-alpha-D-galactopyranose>92.0%(GC)5g

Ytterbium (III) trifluoromethanesulphonate, 90.0%, 25g

(2E)-3-(4-tert-butylphenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Fmoc-D-Dap(Boc)-OH, 95.0%, 10g

(R)-8-Bromochroman-4-amine hydrochloride, 95.0%, 100mg

(R)-tert-Butyl 3-(2-amino-4-fluorophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

(2E)-1-(3-bromophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 2g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 250mg

N-Boc-cis-4-cyano-L-proline methyl ester, 95.0%, 250mg

PRAMIRACETAM, 98%, 5g

Benzyl 3-ethyl-3-hydroxyazetidine-1-carboxylate, 95.0%, 5g

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHOXYPROPANOIC ACID, 95.0%, 250mg